Approval · Notice of Compliance 23819 · 2020
QINLOCK: Notice of Compliance 23819
Issued June 19, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23819
- Date
- June 19, 2020
- Company
- Deciphera Pharmaceuticals. LlcWaltham, Massachusetts, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| QINLOCK | 02500833 | Marketed |
Medicinal ingredients
- RIPRETINIB 50 MG per TAB